At the clinical level, high Fer expression levels have been linked to poor prognosis of hepatocellular-carcinoma (HCC)19, clear cell renal cell carcinoma20, 21, postoperative NSCLC14, and high-grade basal/triple-negative breast cancer22. Here, FER is linked to hepatocellular carcinoma.